Leishmania  LiHyC protein is immunogenic and induces protection against visceral leishmaniasis

Abstract Treatment against visceral leishmaniasis (VL) presents problems by the toxicity of drugs, high cost and/or emergence of resistant strains. The diagnosis is hampered by variable sensitivity and/or specificity of tests. In this context, prophylactic vaccination could represent a control measu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Parasite Immunology. - 44(2022), 8
1. Verfasser:	Machado, Amanda S. (VerfasserIn)
Weitere Verfasser:	Lage, Daniela P., Vale, Danniele L., Freitas, Camila S., Linhares, Flávia P., Cardoso, Jamille M. O., Oliveira‐da‐Silva, João A., Pereira, Isabela A. G., Ramos, Fernanda F., Tavares, Grasiele S. V., Ludolf, Fernanda, Bandeira, Raquel S., Maia, Luiz G. N., Menezes‐Souza, Daniel, Duarte, Mariana C., Chávez‐Fumagalli, Miguel A., Roatt, Bruno M., Christodoulides, Myron, Martins, Vívian T., Coelho, Eduardo Antonio Ferraz
Format:	Online-Aufsatz
Veröffentlicht:	2022
Zugriff auf das übergeordnete Werk:	Parasite Immunology
Umfang:	12